secwatch.observer — SEC 8-K summary
======================================

Issuer:     Compass Therapeutics, Inc. (CMPX)
CIK:        0001738021
Form:       8-K
Filed at:   2025-06-12T23:59:59+00:00
Accession:  0001171843-25-003868
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Compass Therapeutics annual meeting elects three directors, ratifies auditor
----------------------------------------------------------------------------

- Carl L. Gordon, Philip J. Ferneau, and James P. Boylan elected as Class II directors with 80.7M, 58.3M, and 83.6M votes for, respectively.
- Ratification of CohnReznick LLP as auditor for FY2025 approved with 114.3M for, 28,647 against, 22,788 abstain.
- Broker non-votes of 29,432,541 on director election.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1738021/000117184325003868/0001171843-25-003868-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1738021/000117184325003868/f8k_061225.htm
  HTML page:      https://secwatch.observer/filing/0001171843-25-003868

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer